Company profile
Viskase Holdings, Inc. CIK 727510
Tickers
ENZN · VISK (OTC)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Lombard, IL 60148
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$3.41M
Total assets
$42.81M
Total liabilities
—
Stockholders' equity
-$2.53M
Cash & equivalents
$42.57M
Operating income
-$5.31M
Operating cash flow
-$3.01M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-02. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
-5.9%
CapEx / revenue
—
Operating cash flow / net income
0.88×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$3.41M
$42.81M
—
-$2.53M
2024
$26.0K
$778.0K
$47.17M
—
$3.01M
2023
—
$1.37M
$47.70M
—
-$3.51M
2022
$26.0K
-$186.0K
$47.59M
—
$3.41M
2021
$701.0K
-$469.0K
$47.75M
—
$4.87M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-03
Financials filed via
Form 10-K
filed 2026-03-02
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Lombard, IL 60148
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:29 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.